• Contact Us
Pharmaceuticals & Life Sciences Blogs - VWV

Pharma & Life Sciences

Articles & Blogs Pharma & Life Sciences

Recent Data Protection Developments - What Do Life Sciences Organisations Need to Know?

Wednesday, 08 June 2022

Data protection law has been in a state of flux for a number of years now, with the relentless pace of technological development, new ways of working, and external factors such as Brexit, all informing changes in the law and regulatory guidance.

Key Recent Developments in Data Protection - What Do Life Sciences Organisations Need to Know?

Articles & Blogs Pharma & Life Sciences

New UK Medicine Batch Testing Regime - Have Your Say

Wednesday, 08 June 2022

The Department for Health and Social Care is consulting on a new regime for batch testing of medicines which have been imported.

New UK Medicine Batch Testing Regime - Have Your Say

Articles & Blogs Pharma & Life Sciences

Supply and Distribution Agreements - New Competition Law Regime in Force

Wednesday, 08 June 2022

Parties to agreements sometimes include restrictions, such as exclusive territory, minimum purchase requirements, recommended pricing, or some other requirements which may cause a problem under competition law.

Supply and Distribution Agreements - New Competition Law Regime in Force

Articles & Blogs Pharma & Life Sciences

Blockchain - A Solution to the Pain Points in Genomics?

Friday, 20 May 2022

For those working in the Pharmaceuticals and Life Sciences sector, genomics is a familiar subject.

Blockchain - A Solution to the Pain Points in Genomics?

Articles & Blogs Pharma & Life Sciences

What Does 'Contractual Exclusion of Loss of Profits' Mean? Court of Appeal Decides

Tuesday, 10 May 2022

Parties to commercial contracts often look to exclude and limit liability. Those clauses can take many forms. Parties often exclude liability for loss of profits, loss of revenue or loss of savings. But what does this mean?

What Does 'Contractual Exclusion of Loss of Profits' Mean? Court of Appeal Decides

Articles & Blogs Pharma & Life Sciences

Government Launches £200m Programme to Use NHS Data in Research

Wednesday, 06 April 2022

The Government has announced a new £200m programme to enable NHS health data to be used in diagnostics and treatment research.

Government Launches £200m Programme to Use NHS Data in Research

Articles & Blogs Pharma & Life Sciences

Cell and Gene Therapy Catapult Publishes National Cell and Gene Therapy Vision

Wednesday, 06 April 2022

The UK's Cell and Gene Therapy Catapult has published a new National Cell and Gene Therapy Vision.

Cell and Gene Therapy Catapult Publishes National Cell and Gene Therapy Vision

Articles & Blogs Pharma & Life Sciences

£60m of New UK Funding for Life Sciences Innovation Manufacturing

Wednesday, 06 April 2022

£60 million of funding is being made available to support commercial-scale manufacturing by life sciences businesses companies that are at the leading-edge of innovation.

£60m of New UK Funding for Life Sciences Innovation Manufacturing

Articles & Blogs Pharma & Life Sciences

UK Immigration Reforms - Routes to Consider for Pharmaceutical Businesses Attracting Talent from Overseas

Friday, 01 April 2022

In December 2020 changes were made to the UK's Immigration Rules introducing the Government's new, post-Brexit, points-based system.

UK Immigration Reforms - Routes to Consider for Pharmaceutical Businesses Attracting Talent from Overseas

Articles & Blogs Healthcare Pharma & Life Sciences

NHS in Yet Another Negotiated Discounted Deal for Game-Changing Libmeldy Drug

Friday, 11 March 2022

NHS England has agreed another deal for a costly 'game-changing' drug. Orchard Therapeutics usually supplies its Libmeldy gene therapy drug for £2.8m, the most expensive in the world.

NHS in Yet Another Negotiated Discounted Deal for Game-Changing Libmeldy Drug

Articles & Blogs Pharma & Life Sciences

Government Publishes Rare Diseases Action Plan

Tuesday, 01 March 2022

The Government has published the first action plan to show how the Department of Health and Social Care and its delivery partners will implement the UK Rare Diseases Framework in England.

Government Publishes Rare Diseases Action Plan

Articles & Blogs Pharma & Life Sciences

Delivery Time Deemed to Be 'of the Essence' in Informal Contract

Tuesday, 01 March 2022

Phrases are commonly used in agreements such as 'time is of the essence,' but what do they mean? And what happens if the contract is silent?

Delivery Time Deemed to Be 'of the Essence' in Informal Contract

Articles & Blogs Pharma & Life Sciences

MHRA Provides Guidance for Medicine Suppliers Supplying to Northern Ireland

Monday, 07 February 2022

The Medicines and Healthcare products Regulatory Agency (MHRA) is providing a series of guidance to help medicines suppliers to grapple with supplying into Northern Ireland (NI).

MHRA Provides Guidance for Medicine Suppliers Supplying to Northern Ireland

Articles & Blogs Pharma & Life Sciences

High Court Allows COVID-19 Force Majeure Termination - After Disputes Over Who Was 'Affected'

Monday, 07 February 2022

COVID-19 has caused massive disruption to business, and common clauses in contracts have been considered afresh to deal with the situation.

High Court Allows COVID-19 Force Majeure Termination - After Disputes Over Who Was 'Affected'

Articles & Blogs Pharma & Life Sciences

NICE Launches New Flexible Assessment Methods

Wednesday, 02 February 2022

The National Institute for Health and Care Excellence (NICE) has launched a new approach to how it assesses medicines and other health technologies. It aims to provide NHS patients with earlier access to innovative treatments.

NICE Launches New Flexible Assessment Methods